The Philippines Food and Drug Administration (FDA) is seeking comments on draft guidelines to streamline the process for changing labels on pharmaceutical products covered by maximum retail prices (MRPs). In recent years, the Philippines has established and expanded a list of drugs covered by MRPs to ensure access to affordableRead More →

New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has set retail prices for 23 drug formulations, including those used for the treatment of blood pressure and other heart complications, seizures, fever, diabetes and bacterial infections. Few drugs will experience a price increase while most drugs will experience a price decrease.Read More →